Biosimilars Market: Current Analysis and Forecast (2022-2028)


Emphasis on Test Type (Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-Inflammatory Agents, and Others); Application (Oncology, Inflammatory & Autoimmune Disorders, Chronic Diseases, Blood Disorders, and Others); and Region/Country







Report ID:



  Get a Sample
SKU: UMHE211303 Categories: , Tag:
Report Description
Table of content
Research Methodology

Report Description

Biosimilars Market
Biosimilars Market

Global Biosimilars Market is expected to grow at a significant rate of around 18% during the forecast period. The global biosimilars market is anticipated to witness an uptick with the development of social society leading to changes in diet and other lifestyles. This along with the rapidly growing aging population across the globe is causing an increase in the number of chronic disease incidences. For instance, according to the World Health Organization, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. Furthermore, patent expiry of biologics and research on new diseases coupled with the growing focus of key industry players to develop and launch biosimilars in the market is also driving the biosimilars market across the globe. For example, in March 2022, Amneal Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Biologics License Application (BLA) for filgrastim-ayow, a biosimilar referencing Neupogen. The product will be marketed under the proprietary name RELEUKO.

Novartis AG, Pfizer Inc., Dr. Reddy’s Laboratories Ltd., Amgen Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Fresenius Se & Co. KGAA, Boehringer Ingelheim, Intas Pharmaceutical Ltd., Biocon Limited are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products.

Insights Presented in the Report

“Amongst product, monoclonal antibodies category to witness higher CAGR during the forecast period”

Based on the product, the biosimilars market is segmented into monoclonal antibodies, recombinant hormones, immunomodulators, anti-inflammatory agents, and others. The monoclonal antibodies segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe owing to the rising demand for cost-effective treatment options and the wide scope of applications of monoclonal antibodies in treating cancer, autoimmune disorders, and others.

“Amongst application, the oncology segment to hold a significant share in the market in 2020”

Based on application, the market is fragmented into oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and others. The oncology segment is expected to grab a considerable market share in 2020 and is expected to grow with a lucrative CAGR during the forecast period owing to the growing prevalence of cancer and an increase in the number of ongoing studies in the biosimilars filed across the globe.

“North America to hold a significant share in the market”

North America is anticipated to grow at a substantial CAGR during the forecast period. The major factors such as well-established healthcare infrastructure, and rising incidences of chronic diseases. For instance, According to GLOBOCAN 2020, the number of new cancer cases diagnosed was 2,281,658 in the United States in 2020, with 612,390 deaths. Furthermore, rising investment in research and development activities by the key industry players and an increasing pipeline of products & new product launches in the market are also driving the market growth.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
  • The report presents a quick review of overall industry performance at one glance.
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
  • The study comprehensively covers the market across different segments.
  • Deep dive regional level analysis of the industry.


Customization Options:

The global biosimilars market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1.Market Definitions
1.2.Main Objective


2.1.Research Process of the Biosimilars Market
2.2.Research Methodology of the Biosimilars Market
2.3.Respondent Profile   










7.1.Monoclonal Antibodies
7.2.Recombinant Hormones
7.4.Anti-Inflammatory Agents
8.2.Inflammatory & Autoimmune Disorders
8.3.Chronic Diseases 
8.4.Blood Disorders 


9.1.North America   
 9.1.3.Rest of North America
 9.2.6.Rest of Europe
 9.3.4.Rest of Asia-Pacific
9.4.Rest of World  


10.1.Market Drivers
10.2.Market Challenges
10.3.Impact Analysis




13.1.Demand Side Analysis
13.2.Supply Side Analysis
15.1.Competitive Landscape
 15.1.1.Porters Fiver Forces Analysis
16.1.Novartis AG 
16.2.Pfizer Inc. 
16.3.Dr. Reddy’s Laboratories Ltd.
16.4.Amgen Inc. 
16.5.Eli Lilly and Company
16.6.Teva Pharmaceutical Industries Ltd.
16.7.Fresenius Se & Co. KGAA
16.8.Boehringer Ingelheim
16.9.Intas Pharmaceutical Ltd.
16.10.Biocon Limited  




Research Methodology

Research Methodology for the Biosimilars Market Analysis (2022-2028)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global biosimilars market were the three major steps undertaken to create and analyze the adoption of biosimilars in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global biosimilars market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the biosimilars market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the biosimilars market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as product and application. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the biosimilars market. Further, we conducted factor analysis using dependent and independent variables such as various test types and end-user of biosimilars. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the biosimilars market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global biosimilars market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of revenue (USD) and the adoption rate of the biosimilars market across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the global biosimilars market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market


Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Biosimilars Market
Biosimilars Market

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global biosimilars market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of type, and end-user in the global Biosimilars market.

The main objective of the Global Biosimilars Market Study

The current & future market trends of the global Biosimilars market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the biosimilars market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of product and application.
  • Define and analysis of the regulatory framework for the biosimilars
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
  • Analyze the current and forecast market size of the biosimilars market for the major region.
  • Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World.
  • Company profiles of the Biosimilars market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?